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Rabbit articular chondrocytes in monolayer culture were stimulated with human recombinant interleukin-l/J. Under the influence of the cytokine 
the intracellular pool of the cysteine endopeptidase cathepsin B was increased by a 24-fold factor, while enzyme secretion was not stimulated 
at a significant level. Under the same conditions, the secretion of collagenase, measured as an internal control, was stimulated about 6-fold. The 
effects of interleukin-I/? were compared to those caused by phenotypic modulation. Chondrocytes modulated by serial subcultures in monolayer 
secreted more cathepsin B, but less collagenase than differentiated cells (cultured within collagen gels). Thus, interleukin-lg and phenotypic modula- 
tion affected differently two endopeptidases which are relevant in the pathogenesis of osteoarthritis. 
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1. INTRODUCTION 
The activation of articular chondrocytes by cytokines 
of various origin has received great attention in recent 
years because of the possible implication of this 
phenomenon in the pathogenesis of rheumatic diseases. 
The degradation of cartilage components has been 
largely attributed to chrondrocytic collagenase and 
other metal-dependent endopeptidases timulated by 
cytokines from synovium [ 11, monocyte-macrophage 
lineage cells [2], polymorphonuclear leukocytes [3] or 
of autocrine origin [4]. Cartilage degradation has been 
classically observed using organ cultures of this connec- 
tive tissue [5] and the factor responsible for chon- 
drocyte activation has originally been described as 
‘catabolin’ [6]. The co-identity of catabolin and mono- 
nuclear cell factors with IL-l is now established [7]. 
After this discovery, the effects of purified IL-l upon 
chondrocyte metabolism were considered in more detail 
[7-211. 
Another way in which chondrocytes are stimulated to 
synthesize and secrete proteins not normally produced 
by differentiated cells, is phenotypic modulation. The 
interest for proteins from phenotypically-modulated 
chrondrocytes has mainly focused on collagen types 
[22], while only recently attention has been paid in this 
context to cartilage-degrading endopeptidases [23-261. 
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This study shows the effect of IL-1 on the production 
of cathepsin B by articular chondrocytes and compares 
it with the known collagenase-stimulating activity of the 
cytokine, as well as with the effects caused by pheno- 
typic modulation of the cells. 
2. MATERIALS AND METHODS 
Recombinant human IL-1B was a gift of Dr K. Vosbeck, 
Ciba-Geigy Ltd, Base1 Switzerland; indomethacin, dexamethasone 
and cycloheximide were from Sigma, St. Louis, MO, USA, and 
diclofenac sodium was from Ciba-Geigy Ltd. Basel, Switzerland. The 
source of all other materials was specified previously [23,24]. 
Articular chondrocytes were prepared from the pooled hip, knee 
and shoulder cartilages of New Zealand rabbits and cultured in 
monolayers or in collagen gel suspensions [23]. Primary cells were 
cultured to confluence (4-9 days), divided in portions and stored 
frozen until further use. After thawing, the cells were transferred into 
25 cm’ culture flasks with 1 x lo6 cells/flask in 5.0 ml DMEM sup- 
plemented with 10% fetal calf serum. Confluent cells were trypsinized 
and transferred to 24-well culture plates (16 mm diameter) with 
1 .O x lo5 cells/well in 1 .O ml DMEM/IO% fetal calf serum. For col- 
lagen gel cultures, the pellets were prepared by polymerizing 1 .O ml of 
collagen solution, containing 1 .O x 10’ cells, that were incubated with 
2.0 ml DMEM/lO% fetal calf serum. When IL-l was added to the 
cells immediately or within 2-3 days after this transfer, no effects 
upon collagenase stimulation could be observed. We could establish 
that this lack of response was due to destruction of IL-l receptors on 
the chondrocyte cell surface after trypsinization, and that a period of 
5-6 days was necessary to completely restore the receptors. Therefore, 
any experiment with added substances was initiated 6 days after 
transferring the cells into 24-well plates or to collagen gels. Test 
substances were added after dilution of stock solutions with serum- 
free DMEM at the following final concentrations: IL-lb, 10 ng/ml 
(0.59 nM); diclofenac sodium, 1.27 ng/ml(4 nM); indomethacin, 0.36 
pg/ml(l pM); dexamethasone, 0.39pg/ml (PM). All tests were set up 
in quintuplicate in serum-free DMEM (time zero). The culture 
medium was withdrawn after 24 h and 48 h and replaced with fresh 
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serum-free medium containing the appropriate substances. Enzyme 
assays were performed in each of the five media/test collected at 24 
h intervals giving 3 time groups that will be designated as the 24, 48 
and 72 h media. This method was chosen to allow detection of possi- 
ble time-dependent effects upon cell stimulation. Each of the bars 
shown in the figures represents the cumulative enzyme activities of 5 
distinct cultures measured at 3 time intervals for a total of 15 meas- 
urements/bar. 
Cathepsin B and collagenase assays in supernatants and cell 
homogenates were performed as described [23,24,27,28]. The col- 
lagenase assays were performed in the presence of p-aminophenyl- 
mercuric acetate to measure the total enzyme, i.e. latent plus active, 
and were set up within 2 h after sampling to avoid activity losses upon 
freezing and thawing. The media were then stored at -20°C for 
subsequent cathepsin B assays since no losses of activity could be 
observed upon storage for several months and subsequent thawing. 
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Fig. 1. Effect of IL-l,&, diclofenac (Dicl.), indomethacin (Indo.) and 
dexamethasone (Dexa.) on cathepsin B production by rabbit articular 
chondrocytes in monolayer culture. The contributions to the 
cumulative secreted activity of the 24, 48 and 72 h media are shown 
in panel A. The intracellular enzyme was measured after withdrawing 
the last medium at 72 h. The void bars and the shaded bars represent 
two independent series of experiments. Statistical analysis was per- 
formed with the distribution-free Kruskal-Wallis test for assessing 
significant differences between groups, followed by the multiple com- 
parison Dunn’s test of several treatment groups to a control, at a 
significance level cy=O.O5 (two-tailed). As appropriate of non- 
parametric analysis, data are shown as median with standard error of 
the median. The asterix indicates a significant difference from the 
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Fig. 2. Effect of IL-l@, diclofenac (Dicl.), indomethacin (Indo.) and 
dexamethasone (Dexa.) on collagenase secretion by rabbit articular 
chondrocytes in monolayer culture. The experiment was the same as 
that with shaded bars in Fig. 1. Other details and statistics as in 
control. Fig. 1. 
Our collagenase assay with reconstituted collagen fibrils (27,281 
measured EDTA-inhibitable enzyme in excess over possibly present 
collagenase inhibitors [25,26], which were not investigated. 
3. RESULTS AND DISCUSSION 
In this study, aimed at showing variation of enzyme 
activities in either direction, chondrocytes from a first 
subculture were always used to set up the experiments, 
This was necessary, since freshly prepared chondrocytes 
secreted barely measurable cathepsin B levels [23]. The 
cells, whose properties are shown in Figs 1-3, could be 
induced to either secrete more or less cathepsin B, 
depending on the treatment, and were thus chosen as a 
flexible investigation tool. IL-l/3 as well as diclofenac, 
indomethacin and dexamethasone did not stimulate 
further cathepsin B secretion by articular chondrocytes 
(Fig. 1A). The purpose of adding these substances was 
that of testing the effects of two inhibitors of pro- 
staglandin biosynthesis (diclofenac and indomethacin) 
and the effect of a glucocorticoid (dexamethasone). The 
relatively small, although statistically significant varia- 
tions with respect to the control noted in one experi- 
ment were not confirmed in another, independent ex- 
periment (Fig. IA). On the contrary, the accumulation 
of cathepsin B in intracellular granules was regularly 
stimulated by a factor 2-4 in the presence of IL-lb, an 
effect not contrasted by prostaglandin inhibitors 
(Fig. 1B). For checking the validity of the experimental 
conditions, the known effects of IL-1P and of the other 
test substances upon collagenase secretion were 
measured. As shown in Fig. 2, collagenase secretion 
was enhanced by a factor of =6 in the presence of 
IL-l/3, an effect not counteracted by diclofenac and in- 
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Fig. 3. Comparison of cathepsin B and collagenase secretion in 
monolayer and collagen gel cultures. The same cell stock was cultured 
with both methods and the media were collected at 24 h intervals for 
3 days. Since statistical analysis was performed with a parametric 
method, bars represent he cumulative activity as mean with SD. 
domethacin at concentrations known to inhibit pro- 
stagiandin synthesis. This confirms that prostaglandins 
and metallo-endopeptidases are independently 
regulated in chondrocytes [19,29], and the same con- 
cept seems to be valid for the intracellular accumulation 
of cathepsin B. Intracellular collagenase was never 
found. Since the collagenase data reproduce those 
published by other investigators [8,9,11,14,19], the con- 
ditions used for cathepsin B measurements in Fig. I are 
likely to be safe. Enzyme secretion was directly depen- 
dent upon protein synthesis, since cycloheximide (1 
Fg/ml) strongly reduced both collagenase and cathepsin 
B levels (data not shown, for cathepsin B see [24]). Dex- 
amethasqne could efficiently counteract he stimulatory 
effect of IL-l,& upon collagenase secretion (Fig. 2) and 
could also moderately, but significantly interfere with 
the intracellular accumulation of cathepsin B (Fig. 1B). 
These effects are in line with literature data [30,31] that 
suggest a mechanism of action of dexamethasone at the 
transcriptional level by decreasing the mRNAs of 
various proteins through receptor-mediated inhibition 
of gene expression. 
The same cell stock used in the experiments of Figs. 1 
and 2 was used to show in parallel the effect of 
Table I 
Effects of IL-ip stimulation and subculture modulation on cathepsin 
B and collagenase production by rabbit articular chondrocytes. (1, t* 
tP ttt) qualitative scale for reduction or stimulation, from moderate 
to very strong 
IL-18 Modulation 
c 
Intracellular t Ttt 
Cathepsin B 
Secreted Unchanged ttt 
Collagenase (Secreted) ft & 
phenotypic modulation upon the secretion of cathepsin 
B and collagenase. Chondrocytes cultured within a 
three-dimensional matrix, such as a collagen gel, are 
considered to represent the differentiated phenotype 
while cells cultured in monolayer are representative of a 
modulated phenotype [22]. Fig. 3 compares parallel ex- 
periments on the secretion of cathepsin B and col- 
lagenase by chondrocytes cultured in monolayers and 
within collagen gels. With respect to the monolayer 
cultures, cathepsin B secretion was drastically reduced 
in the collagen gel cultures. Collagenase secretion was 
relatively low in monolayers, but significantly higher 
than blanks, and was nearly quadruplicated at a very 
significant statistical evel in collagen cultures. When 
the cells cultured in monolayer (experiments in Fig. 3) 
where further passaged to a fifth subculture, cathepsin 
B secretion was triplicated, whereas collagenase secre- 
tion remained constant (not shown, data confirming 
previous results [23]). 
IL-l has been implicated in the pathogenesis of 
osteoarthritis [32] and has been localized in human 
osteoarthritic synovium as well as cartilage [33], thus 
suggesting a role of inflammation in the 
pathophysiology of osteoarthritis. However, other 
aspects of osteoarhritis, such as the switch from col- 
lagen type II to type I synthesis [22] and the production 
of cathepsin B [23,34], we believe can now be ascribed 
to phenotypic changes on the part of the chondrocytes 
rather than to IL-l stimulation (see Table I). It is thus 
possible that these two routes of chondrocyte activation 
in osteoarthritis either coexist or that they represent 
episodes occurring independently at different times dur- 
ing the development of the disease. 
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